651 related articles for article (PubMed ID: 19709553)
21. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
[TBL] [Abstract][Full Text] [Related]
22. Isolated tumor cells in the sentinel node affect long-term prognosis of patients with melanoma.
Scheri RP; Essner R; Turner RR; Ye X; Morton DL
Ann Surg Oncol; 2007 Oct; 14(10):2861-6. PubMed ID: 17882497
[TBL] [Abstract][Full Text] [Related]
23. Incomplete sentinel node biopsy is not clearly related to survival or regional recurrence in cutaneous melanoma patients.
Lee NC; Spillane AJ; Pang TC; Haydu LE; Uren RF
Ann Surg Oncol; 2012 Jan; 19(1):280-6. PubMed ID: 21833669
[TBL] [Abstract][Full Text] [Related]
24. Sentinel lymph node biopsy in patients with thin melanoma: occurrence of nodal metastases and its prognostic value.
Vermeeren L; Van der Ent F; Sastrowijoto P; Hulsewé K
Eur J Dermatol; 2010; 20(1):30-4. PubMed ID: 19889594
[TBL] [Abstract][Full Text] [Related]
25. Factors predictive of nonsentinel lymph node involvement and clinical outcome in melanoma patients with metastatic sentinel lymph node.
Rossi CR; De Salvo GL; Bonandini E; Mocellin S; Foletto M; Pasquali S; Pilati P; Lise M; Nitti D; Rizzo E; Montesco MC
Ann Surg Oncol; 2008 Apr; 15(4):1202-10. PubMed ID: 18165880
[TBL] [Abstract][Full Text] [Related]
26. A sentinel node biopsy does not increase the incidence of in-transit metastasis in patients with primary cutaneous melanoma.
van Poll D; Thompson JF; Colman MH; McKinnon JG; Saw RP; Stretch JR; Scolyer RA; Uren RF
Ann Surg Oncol; 2005 Aug; 12(8):597-608. PubMed ID: 16021534
[TBL] [Abstract][Full Text] [Related]
27. Sentinel node biopsy in malignant melanoma: Swedish experiences 1997-2005.
Mattsson J; Bergkvist L; Abdiu A; Aili Low JF; Naredi P; Ullberg K; Garpered U; Håkansson A; Ingvar C
Acta Oncol; 2008; 47(8):1519-25. PubMed ID: 18941953
[TBL] [Abstract][Full Text] [Related]
28. Head and neck cutaneous melanoma: a retrospective observational study on 146 patients.
Koskivuo IO; Kinnunen IA; Suominen EA; Talve LA; Vihinen PP; Grénman RA
Acta Oncol; 2009; 48(3):460-7. PubMed ID: 18843562
[TBL] [Abstract][Full Text] [Related]
29. Short-term morbidity associated with sentinel lymph node biopsy in cutaneous malignant melanoma.
Ling A; Dawkins R; Bailey M; Leung M; Cleland H; Serpell J; Kelly J
Australas J Dermatol; 2010 Feb; 51(1):13-7. PubMed ID: 20148833
[TBL] [Abstract][Full Text] [Related]
30. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
[TBL] [Abstract][Full Text] [Related]
31. Sentinel lymph node biopsy in melanoma patients: the medical oncologist's perspective.
Queirolo P; Taveggia P; Gipponi M; Sertoli MR
J Surg Oncol; 2004 Mar; 85(3):162-5. PubMed ID: 14991888
[TBL] [Abstract][Full Text] [Related]
32. Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma.
Taylor RC; Patel A; Panageas KS; Busam KJ; Brady MS
J Clin Oncol; 2007 Mar; 25(7):869-75. PubMed ID: 17327608
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of sentinel node biopsy in 327 prospective melanoma patients from a single institution.
Roulin D; Matter M; Bady P; Liénard D; Gugerli O; Boubaker A; Bron L; Lejeune FJ
Eur J Surg Oncol; 2008 Jun; 34(6):673-9. PubMed ID: 17825518
[TBL] [Abstract][Full Text] [Related]
34. The complex relationships between sentinel node positivity, patient age, and primary tumor desmoplasia: analysis of 2303 melanoma patients treated at a single center.
Sassen S; Shaw HM; Colman MH; Scolyer RA; Thompson JF
Ann Surg Oncol; 2008 Feb; 15(2):630-7. PubMed ID: 18080717
[TBL] [Abstract][Full Text] [Related]
35. Our experience of melanoma thickness as a predictor of outcome of sentinel node biopsy.
Homolak D; Vucetić B; Puljiz Z; Blajć I; Vurnek Zivković M; Situm M
Coll Antropol; 2008 Oct; 32 Suppl 2():57-60. PubMed ID: 19138008
[TBL] [Abstract][Full Text] [Related]
36. Sentinel lymph node biopsy for melanoma and other melanocytic tumors in adolescents.
Roaten JB; Partrick DA; Pearlman N; Gonzalez RJ; Gonzalez R; McCarter MD
J Pediatr Surg; 2005 Jan; 40(1):232-5. PubMed ID: 15868590
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of extent of ulceration in primary cutaneous melanoma.
Grande Sarpa H; Reinke K; Shaikh L; Leong SP; Miller JR; Sagebiel RW; Kashani-Sabet M
Am J Surg Pathol; 2006 Nov; 30(11):1396-400. PubMed ID: 17063079
[TBL] [Abstract][Full Text] [Related]
38. Patterns of first-recurrence and post-recurrence survival in patients with primary cutaneous melanoma after sentinel lymph node biopsy.
Dalal KM; Patel A; Brady MS; Jaques DP; Coit DG
Ann Surg Oncol; 2007 Jun; 14(6):1934-42. PubMed ID: 17406951
[TBL] [Abstract][Full Text] [Related]
39. Sentinel node biopsy in patients with cutaneous melanoma of the head and neck: recurrence and survival study.
Gomez-Rivera F; Santillan A; McMurphey AB; Paraskevopoulos G; Roberts DB; Prieto VG; Myers JN
Head Neck; 2008 Oct; 30(10):1284-94. PubMed ID: 18704971
[TBL] [Abstract][Full Text] [Related]
40. Age as predictor in patients with cutaneous melanoma submitted to sentinel lymph node biopsy.
Caracò C; Marone U; Botti G; Celentano E; Lastoria S; Mozzillo N
Eur J Surg Oncol; 2006 Nov; 32(9):970-3. PubMed ID: 16996239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
